Is JHX Stock a Buy Sell or Hold?
James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…
Sell
42
XLV Quote, Financials, Valuation and Earnings
Last price:
$144.56
Seasonality move
:
2.9%
Day range:
$144.45 - $145.24
52-week range:
$135.95 - $159.64
Dividend yield:
1.62%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
6.2M
Avg. volume:
7.9M
1-year change:
-2.17%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
XLV
Health Care Select Sector SPDR Fund
|
-- | -- | -- | -- | -- |
|
FHLC
Fidelity MSCI Health Care Index ETF
|
-- | -- | -- | -- | -- |
|
IHE
iShares US Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
|
IYH
iShares US Healthcare ETF
|
-- | -- | -- | -- | -- |
|
RXL
ProShares Ultra Health Care
|
-- | -- | -- | -- | -- |
|
VHT
Vanguard Health Care Index Fund ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
XLV
Health Care Select Sector SPDR Fund
|
$144.52 | -- | -- | -- | $0.56 | 1.62% | -- |
|
FHLC
Fidelity MSCI Health Care Index ETF
|
$67.74 | -- | -- | -- | $0.25 | 1.48% | -- |
|
IHE
iShares US Pharmaceuticals ETF
|
$68.56 | -- | -- | -- | $0.29 | 1.69% | -- |
|
IYH
iShares US Healthcare ETF
|
$60.37 | -- | -- | -- | $0.16 | 1.2% | -- |
|
RXL
ProShares Ultra Health Care
|
$48.08 | -- | -- | -- | $0.13 | 1.21% | -- |
|
VHT
Vanguard Health Care Index Fund ETF
|
$262.90 | -- | -- | -- | $0.94 | 1.52% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
XLV
Health Care Select Sector SPDR Fund
|
-- | 1.132 | -- | -- |
|
FHLC
Fidelity MSCI Health Care Index ETF
|
-- | 1.193 | -- | -- |
|
IHE
iShares US Pharmaceuticals ETF
|
-- | 0.886 | -- | -- |
|
IYH
iShares US Healthcare ETF
|
-- | 1.117 | -- | -- |
|
RXL
ProShares Ultra Health Care
|
-- | 1.717 | -- | -- |
|
VHT
Vanguard Health Care Index Fund ETF
|
-- | 1.198 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
XLV
Health Care Select Sector SPDR Fund
|
-- | -- | -- | -- | -- | -- |
|
FHLC
Fidelity MSCI Health Care Index ETF
|
-- | -- | -- | -- | -- | -- |
|
IHE
iShares US Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
|
IYH
iShares US Healthcare ETF
|
-- | -- | -- | -- | -- | -- |
|
RXL
ProShares Ultra Health Care
|
-- | -- | -- | -- | -- | -- |
|
VHT
Vanguard Health Care Index Fund ETF
|
-- | -- | -- | -- | -- | -- |
Health Care Select Sector SPDR Fund vs. Competitors
-
Which has Higher Returns XLV or FHLC?
Fidelity MSCI Health Care Index ETF has a net margin of -- compared to Health Care Select Sector SPDR Fund's net margin of --. Health Care Select Sector SPDR Fund's return on equity of -- beat Fidelity MSCI Health Care Index ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XLVHealth Care Select Sector SPDR Fund-- -- -- FHLCFidelity MSCI Health Care Index ETF-- -- -- -
What do Analysts Say About XLV or FHLC?
Health Care Select Sector SPDR Fund has a consensus price target of --, signalling downside risk potential of --. On the other hand Fidelity MSCI Health Care Index ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Health Care Select Sector SPDR Fund has higher upside potential than Fidelity MSCI Health Care Index ETF, analysts believe Health Care Select Sector SPDR Fund is more attractive than Fidelity MSCI Health Care Index ETF.
Company Buy Ratings Hold Ratings Sell Ratings XLVHealth Care Select Sector SPDR Fund0 0 0 FHLCFidelity MSCI Health Care Index ETF0 0 0 -
Is XLV or FHLC More Risky?
Health Care Select Sector SPDR Fund has a beta of 0.677, which suggesting that the stock is 32.271% less volatile than S&P 500. In comparison Fidelity MSCI Health Care Index ETF has a beta of 0.715, suggesting its less volatile than the S&P 500 by 28.484%.
-
Which is a Better Dividend Stock XLV or FHLC?
Health Care Select Sector SPDR Fund has a quarterly dividend of $0.56 per share corresponding to a yield of 1.62%. Fidelity MSCI Health Care Index ETF offers a yield of 1.48% to investors and pays a quarterly dividend of $0.25 per share. Health Care Select Sector SPDR Fund pays -- of its earnings as a dividend. Fidelity MSCI Health Care Index ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XLV or FHLC?
Health Care Select Sector SPDR Fund quarterly revenues are --, which are smaller than Fidelity MSCI Health Care Index ETF quarterly revenues of --. Health Care Select Sector SPDR Fund's net income of -- is lower than Fidelity MSCI Health Care Index ETF's net income of --. Notably, Health Care Select Sector SPDR Fund's price-to-earnings ratio is -- while Fidelity MSCI Health Care Index ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Health Care Select Sector SPDR Fund is -- versus -- for Fidelity MSCI Health Care Index ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XLVHealth Care Select Sector SPDR Fund-- -- -- -- FHLCFidelity MSCI Health Care Index ETF-- -- -- --
-
Which has Higher Returns XLV or IHE?
iShares US Pharmaceuticals ETF has a net margin of -- compared to Health Care Select Sector SPDR Fund's net margin of --. Health Care Select Sector SPDR Fund's return on equity of -- beat iShares US Pharmaceuticals ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XLVHealth Care Select Sector SPDR Fund-- -- -- IHEiShares US Pharmaceuticals ETF-- -- -- -
What do Analysts Say About XLV or IHE?
Health Care Select Sector SPDR Fund has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Health Care Select Sector SPDR Fund has higher upside potential than iShares US Pharmaceuticals ETF, analysts believe Health Care Select Sector SPDR Fund is more attractive than iShares US Pharmaceuticals ETF.
Company Buy Ratings Hold Ratings Sell Ratings XLVHealth Care Select Sector SPDR Fund0 0 0 IHEiShares US Pharmaceuticals ETF0 0 0 -
Is XLV or IHE More Risky?
Health Care Select Sector SPDR Fund has a beta of 0.677, which suggesting that the stock is 32.271% less volatile than S&P 500. In comparison iShares US Pharmaceuticals ETF has a beta of 0.633, suggesting its less volatile than the S&P 500 by 36.663%.
-
Which is a Better Dividend Stock XLV or IHE?
Health Care Select Sector SPDR Fund has a quarterly dividend of $0.56 per share corresponding to a yield of 1.62%. iShares US Pharmaceuticals ETF offers a yield of 1.69% to investors and pays a quarterly dividend of $0.29 per share. Health Care Select Sector SPDR Fund pays -- of its earnings as a dividend. iShares US Pharmaceuticals ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XLV or IHE?
Health Care Select Sector SPDR Fund quarterly revenues are --, which are smaller than iShares US Pharmaceuticals ETF quarterly revenues of --. Health Care Select Sector SPDR Fund's net income of -- is lower than iShares US Pharmaceuticals ETF's net income of --. Notably, Health Care Select Sector SPDR Fund's price-to-earnings ratio is -- while iShares US Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Health Care Select Sector SPDR Fund is -- versus -- for iShares US Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XLVHealth Care Select Sector SPDR Fund-- -- -- -- IHEiShares US Pharmaceuticals ETF-- -- -- --
-
Which has Higher Returns XLV or IYH?
iShares US Healthcare ETF has a net margin of -- compared to Health Care Select Sector SPDR Fund's net margin of --. Health Care Select Sector SPDR Fund's return on equity of -- beat iShares US Healthcare ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XLVHealth Care Select Sector SPDR Fund-- -- -- IYHiShares US Healthcare ETF-- -- -- -
What do Analysts Say About XLV or IYH?
Health Care Select Sector SPDR Fund has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Healthcare ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Health Care Select Sector SPDR Fund has higher upside potential than iShares US Healthcare ETF, analysts believe Health Care Select Sector SPDR Fund is more attractive than iShares US Healthcare ETF.
Company Buy Ratings Hold Ratings Sell Ratings XLVHealth Care Select Sector SPDR Fund0 0 0 IYHiShares US Healthcare ETF0 0 0 -
Is XLV or IYH More Risky?
Health Care Select Sector SPDR Fund has a beta of 0.677, which suggesting that the stock is 32.271% less volatile than S&P 500. In comparison iShares US Healthcare ETF has a beta of 0.692, suggesting its less volatile than the S&P 500 by 30.803%.
-
Which is a Better Dividend Stock XLV or IYH?
Health Care Select Sector SPDR Fund has a quarterly dividend of $0.56 per share corresponding to a yield of 1.62%. iShares US Healthcare ETF offers a yield of 1.2% to investors and pays a quarterly dividend of $0.16 per share. Health Care Select Sector SPDR Fund pays -- of its earnings as a dividend. iShares US Healthcare ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XLV or IYH?
Health Care Select Sector SPDR Fund quarterly revenues are --, which are smaller than iShares US Healthcare ETF quarterly revenues of --. Health Care Select Sector SPDR Fund's net income of -- is lower than iShares US Healthcare ETF's net income of --. Notably, Health Care Select Sector SPDR Fund's price-to-earnings ratio is -- while iShares US Healthcare ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Health Care Select Sector SPDR Fund is -- versus -- for iShares US Healthcare ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XLVHealth Care Select Sector SPDR Fund-- -- -- -- IYHiShares US Healthcare ETF-- -- -- --
-
Which has Higher Returns XLV or RXL?
ProShares Ultra Health Care has a net margin of -- compared to Health Care Select Sector SPDR Fund's net margin of --. Health Care Select Sector SPDR Fund's return on equity of -- beat ProShares Ultra Health Care's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XLVHealth Care Select Sector SPDR Fund-- -- -- RXLProShares Ultra Health Care-- -- -- -
What do Analysts Say About XLV or RXL?
Health Care Select Sector SPDR Fund has a consensus price target of --, signalling downside risk potential of --. On the other hand ProShares Ultra Health Care has an analysts' consensus of -- which suggests that it could fall by --. Given that Health Care Select Sector SPDR Fund has higher upside potential than ProShares Ultra Health Care, analysts believe Health Care Select Sector SPDR Fund is more attractive than ProShares Ultra Health Care.
Company Buy Ratings Hold Ratings Sell Ratings XLVHealth Care Select Sector SPDR Fund0 0 0 RXLProShares Ultra Health Care0 0 0 -
Is XLV or RXL More Risky?
Health Care Select Sector SPDR Fund has a beta of 0.677, which suggesting that the stock is 32.271% less volatile than S&P 500. In comparison ProShares Ultra Health Care has a beta of 1.401, suggesting its more volatile than the S&P 500 by 40.142%.
-
Which is a Better Dividend Stock XLV or RXL?
Health Care Select Sector SPDR Fund has a quarterly dividend of $0.56 per share corresponding to a yield of 1.62%. ProShares Ultra Health Care offers a yield of 1.21% to investors and pays a quarterly dividend of $0.13 per share. Health Care Select Sector SPDR Fund pays -- of its earnings as a dividend. ProShares Ultra Health Care pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XLV or RXL?
Health Care Select Sector SPDR Fund quarterly revenues are --, which are smaller than ProShares Ultra Health Care quarterly revenues of --. Health Care Select Sector SPDR Fund's net income of -- is lower than ProShares Ultra Health Care's net income of --. Notably, Health Care Select Sector SPDR Fund's price-to-earnings ratio is -- while ProShares Ultra Health Care's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Health Care Select Sector SPDR Fund is -- versus -- for ProShares Ultra Health Care. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XLVHealth Care Select Sector SPDR Fund-- -- -- -- RXLProShares Ultra Health Care-- -- -- --
-
Which has Higher Returns XLV or VHT?
Vanguard Health Care Index Fund ETF has a net margin of -- compared to Health Care Select Sector SPDR Fund's net margin of --. Health Care Select Sector SPDR Fund's return on equity of -- beat Vanguard Health Care Index Fund ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XLVHealth Care Select Sector SPDR Fund-- -- -- VHTVanguard Health Care Index Fund ETF-- -- -- -
What do Analysts Say About XLV or VHT?
Health Care Select Sector SPDR Fund has a consensus price target of --, signalling downside risk potential of --. On the other hand Vanguard Health Care Index Fund ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Health Care Select Sector SPDR Fund has higher upside potential than Vanguard Health Care Index Fund ETF, analysts believe Health Care Select Sector SPDR Fund is more attractive than Vanguard Health Care Index Fund ETF.
Company Buy Ratings Hold Ratings Sell Ratings XLVHealth Care Select Sector SPDR Fund0 0 0 VHTVanguard Health Care Index Fund ETF0 0 0 -
Is XLV or VHT More Risky?
Health Care Select Sector SPDR Fund has a beta of 0.677, which suggesting that the stock is 32.271% less volatile than S&P 500. In comparison Vanguard Health Care Index Fund ETF has a beta of 0.719, suggesting its less volatile than the S&P 500 by 28.082%.
-
Which is a Better Dividend Stock XLV or VHT?
Health Care Select Sector SPDR Fund has a quarterly dividend of $0.56 per share corresponding to a yield of 1.62%. Vanguard Health Care Index Fund ETF offers a yield of 1.52% to investors and pays a quarterly dividend of $0.94 per share. Health Care Select Sector SPDR Fund pays -- of its earnings as a dividend. Vanguard Health Care Index Fund ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XLV or VHT?
Health Care Select Sector SPDR Fund quarterly revenues are --, which are smaller than Vanguard Health Care Index Fund ETF quarterly revenues of --. Health Care Select Sector SPDR Fund's net income of -- is lower than Vanguard Health Care Index Fund ETF's net income of --. Notably, Health Care Select Sector SPDR Fund's price-to-earnings ratio is -- while Vanguard Health Care Index Fund ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Health Care Select Sector SPDR Fund is -- versus -- for Vanguard Health Care Index Fund ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XLVHealth Care Select Sector SPDR Fund-- -- -- -- VHTVanguard Health Care Index Fund ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Buffett Sell the S&P 500?
Warren Buffett has always been an advocate of investing in…
Will SoundHound AI Stock Recover?
SoundHound AI (NASDAQ:SOUN) is a leading maker of artificial intelligence…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
78
AJINY alert for Mar 29
Ajinomoto [AJINY] is up 99.61% over the past day.
Buy
69
AGX alert for Mar 29
Argan [AGX] is up 19.83% over the past day.
Sell
24
AIR alert for Mar 29
AAR [AIR] is down 16.36% over the past day.
